fig2
![Changes in hepatic fibrosis and incidence of HCC following direct-acting antiviral treatment of F3 chronic hepatitis c patients: a prospective observational study](https://image.oaes.cc/a64dc854-654e-4a24-a157-282bdd2262b0/5000.fig.2.jpg)
Figure 2. Change in liver fibrosis after DAAs. DAAs: Direct acting antivirals.
Figure 2. Change in liver fibrosis after DAAs. DAAs: Direct acting antivirals.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/